Filing Details
- Accession Number:
- 0001209191-18-051494
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-09-18 16:56:21
- Reporting Period:
- 2018-09-18
- Accepted Time:
- 2018-09-18 16:56:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1649989 | Oncobiologics Inc. | ONS | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1230484 | A Lawrence Kenyon | C/O Oncobiologics, Inc. 7 Clarke Drive Cranbury NJ 08512 | Ceo, Pres, Cfo, Treas & Secy | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2018-09-18 | 10,100 | $0.87 | 57,213 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the settlement of vested restricted stock units ("RSUs"). This sale is mandated by the Issuer's election under its equity incentive plans to require the Reporting Person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.855 - $0.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
- Includes 21,739 shares of the Issuer's common stock subject to RSUs that will vest on 9/15/2019, subject to continued service through such date.